Recombinant Human M-CSF R

Referência M1237-100

Tamanho : 100ug

Marca : Leinco Technologies

Contactar o distribuidor local :


Telefone : +1 850 650 7790

Recombinant Human MCSF R

Product No.: M1237

[product_table name="All Top" skus="M1237"]

Alternate Names
CSF1R, CFMS, CD115, CSFR, FIM2, FMS
Product Type
Recombinant Protein
Expression Host
NS0 Cells
Species
Human

Background

Macrophage colonystimulating factor (MCSF, also termed CSF1) receptor is an integral membrane tyrosine kinase, expressed in monocytes (macrophages and their progenitors) and drives growth and development of this blood cell lineage.1,2,3 It also triggers growth and development of mononuclear phagocytes and placental trophoblasts.4 MCSF receptor is present in osteoclasts both at mRNA and protein levels. When MCSF ligand specifically binds to the MCSF receptor on osteoclasts, it induces receptor dimerization, activation and autophosphorylation of cytoplasmic tyrosine residues5 MCSF and its receptor present as candidate therapeutic targets in states of inflammatory bone erosion.6

Protein Details

Purity
>97% by SDSPAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Fusion Protein Tag
Fc Fusion Protein
Protein Accession No.
CAA27300
Amino Acid Sequence
i pviepsvpel vvkpgatvtl rcvgngsvew dgpasphwtl ysdgsssils tnnatfqntg tyrctepgdp lggsaaihly vkdparpwnv laqevvvfed qdallpcllt dpvleagvsl vrvrgrplmr htnysfspwh gftihrakfi qsqdyqcsal mggrkvmsis irlkvqkvip gppaltlvpa elvrirgeaa qivcsassvd vnfdvflqhn ntklaipqqs dfhnnryqkv ltlnldqvdf qhagnyscva snvqgkhsts mffrvvesay lnlsseqnli qevtvgegln lkvmveaypg lqgfnwtylg pfsdhqpepk lanattkdty rhtftlslpr lkpseagrys flarnpggwr altfeltlry ppevsviwtf ingsgtllca asgypqpnvt wlqcsghtdr cdeaqvlqvw ddpypevlsq epfhkvtvqs lltvetlehn qtyecrahns vgsgswafip isagahthpp dediegrmdp kscdkthtcp pcpapellgg psvflfppkp kdtlmisrtp evtcvvvdvs hedpevkfnw yvdgvevhna ktkpreeqyn styrvvsvlt vlhqdwlngk eykckvsnka lpapiektis kakgqprepq vytlppsrde ltknqvsltc lvkgfypsdi avewesngqp ennykttppv ldsdgsffly skltvdksrw qqgnvfscsv mhealhnhyt qkslslspgk hhhhhh
Nterminal Sequence Analysis
Ile20
State of Matter
Lyophilized
Predicted Molecular Mass
The predicted molecular weight of Recombinant Human MCSF R is Mr 81 kDa. However, as a result of glycosylation, the actual molecular weight of the monomer as observed by migration on SDSPAGE is Mr 150 kDa.
Predicted Molecular Mass
81
Formulation
This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.
Storage and Stability
This lyophilized protein is stable for six to twelve months when stored desiccated at 20°C to 70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at 20°C to 70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Country of Origin
USA
Shipping
Next Day Ambient
NCBI Gene Bank

Leinco Protein Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Recombinant human MCSF (macrophage colonystimulating factor) offers substantial scientific value across multiple research applications due to its diverse biological functions and wellcharacterized mechanisms of action.

Key Biological Functions

MCSF serves as a critical regulator of myeloid cell development and function. It plays an essential role in the survival, proliferation, and differentiation of hematopoietic precursor cells, particularly mononuclear phagocytes. The cytokine binds to CD14+ monocytes and promotes their survival and proliferation, making it invaluable for studies involving monocyte and macrophage biology.

Enhanced Cellular Capabilities

When applied to monocytes and macrophages, recombinant MCSF significantly enhances multiple functional properties. The protein primes and amplifies macrophage killing of both tumor cells and microorganisms, regulates the release of cytokines and inflammatory modulators, and stimulates pinocytosis. Additionally, MCSF enhances inducible monocyte functions including phagocytic activity, microbial killing, cytotoxicity for tumor cells, and synthesis of inflammatory cytokines such as IL1, TNFα, and IFNγ.

Immunological Applications

In infection models, recombinant MCSF demonstrates remarkable protective capacity. Studies show that MCSF treatment substantially improves survival rates in hematopoietic cell transplant recipients facing lethal infections, with survival improvements from 15.3% in controls to 87.5% in treated mice against bacterial pathogens, and significant reductions in fungal tissue load. This protective effect occurs through increased myelopoiesis and enhanced donorderived cell recovery, even with singledose treatments.

Bone and Skeletal Research

MCSF plays a critical regulatory role in osteoclast biology. The cytokine regulates osteoclast proliferation and differentiation, controls bone resorption, and is required for normal bone development. MCSF induces RANKL production in mature osteoclasts, making it a potent stimulator of osteoclast resorbing activity.

Experimental Versatility

Recombinant MCSF is suitable for diverse experimental approaches including bioassays with cell lines, whole cell culture systems, and functional assays measuring proliferation and differentiation. The availability of both standard and GMPgrade formulations allows flexibility for basic research through to more stringent applications.

Recombinant Human MCSF R (CSF1R) can be used as a standard for quantification or calibration in ELISA assays only if the assay is specifically designed to detect and quantify the receptor protein (CSF1R), not the ligand (MCSF). For ELISAs targeting MCSF quantification, the standard must be recombinant MCSF, not its receptor.

Essential context and supporting details:

  • ELISA Standards Must Match the Target: In ELISA assays, the standard should be the same molecule as the analyte being measured. If your assay is designed to quantify MCSF, you must use recombinant human MCSF as the standard. If your assay is designed to quantify MCSF R (CSF1R), then recombinant human MCSF R is appropriate as the standard.

  • AssaySpecific Calibration: Commercial ELISA kits for MCSF quantification use recombinant human MCSF, calibrated against international standards (e.g., NIBSC/WHO). Kits for CSF1R quantification use recombinant CSF1R as the standard.

  • Protocol Requirements: When using recombinant proteins as standards, ensure:

    • The protein is of high purity and properly formulated (e.g., in PBS, low endotoxin).
    • The standard curve is generated using serial dilutions of the recombinant protein within the assay's detection range.
    • The recombinant standard matches the form (e.g., glycosylation, dimerization) of the native protein as closely as possible for accurate quantification.
  • Limitations: Using the wrong recombinant protein (e.g., CSF1R as a standard for MCSF quantification) will yield inaccurate results, as the antibodies in the ELISA are specific to the target analyte.

Summary Table:

ELISA TargetAppropriate StandardExample Kit Reference
MCSF (ligand)Recombinant Human MCSF
MCSF R (CSF1R)Recombinant Human MCSF R

Best Practices:

  • Always verify the specificity of your ELISA antibodies and the intended analyte.
  • Use recombinant standards that match the analyte in structure and sequence.
  • Follow the kit or protocol instructions for standard preparation and calibration.

If your goal is to quantify MCSF R (CSF1R), you may use recombinant human MCSF R as a standard. If you intend to quantify MCSF, you must use recombinant human MCSF as the standard.

Recombinant Human MCSF R (Macrophage ColonyStimulating Factor Receptor, also known as CSF1R or CD115) has been validated in published research primarily for bioassays, cell signaling studies, and cell culture applications involving monocyte/macrophage lineage cells.

Key validated applications in published research include:

  • Bioassays: Recombinant Human MCSF R is widely used in bioassays to study ligandreceptor interactions, particularly the binding and signaling of MCSF and IL34, which are its physiological ligands. These assays often measure downstream effects such as receptor phosphorylation, activation of signaling pathways, and functional cellular responses like proliferation, survival, and differentiation of monocytes and macrophages.

  • Cell Signaling Studies: The receptor is used to investigate the molecular mechanisms of MCSFinduced signal transduction, including receptor dimerization, tyrosine phosphorylation, and recruitment of intracellular signaling proteins that regulate cell proliferation, survival, and cytoskeletal reorganization.

  • Cell Culture and Differentiation: Recombinant MCSF R has been applied in cell culture systems to support the differentiation and maintenance of macrophages, microglia, and osteoclasts from precursor cells. It is also used to model disease processes and study the effects of MCSF/CSF1R signaling in various cell types, including stem cellderived macrophages and tissueresident macrophages.

  • Disease Modeling and Therapeutic Research: The MCSF/CSF1R axis is a target in preclinical models of cancer, rheumatoid arthritis, neurodegenerative diseases, and inflammatory conditions. Recombinant MCSF R is used to validate the effects of inhibitors, antibodies, or other modulators of this pathway in vitro and in vivo.

  • ProteinProtein Interaction and Binding Assays: The recombinant receptor is used in binding assays to characterize interactions with ligands (MCSF, IL34) and to screen for potential therapeutic inhibitors or antibodies that block receptor function.

Representative published research applications:

  • Analysis of macrophage and microglia development and function in coculture and organotypic models.
  • Investigation of CSF1R signaling in cancer, including tumorassociated macrophage biology and tumor microenvironment studies.
  • Studies of inflammatory and neurodegenerative disease mechanisms, including the role of CSF1R in microglial proliferation and activation.
  • Validation of CSF1R as a therapeutic target using recombinant protein in preclinical models.

Summary Table:

Application TypeDescription/Use Case
BioassayLigand binding, receptor activation, downstream signaling analysis
Cell Culture/DifferentiationSupport of macrophage, microglia, osteoclast differentiation from precursors
Disease ModelingCancer, rheumatoid arthritis, neurodegeneration, inflammatory disease studies
ProteinProtein InteractionBinding assays for ligand/receptor and inhibitor screening

References:

  • : Bioassay, cell signaling, and protein interaction applications
  • : Cell culture, macrophage differentiation, and disease modeling
  • : Disease modeling, therapeutic research, and neurobiology
  • : Binding assays, cell differentiation, and proliferation studies

If you need protocols or more specific examples from the literature, please specify the cell type or disease model of interest.

To reconstitute and prepare Recombinant Human MCSF R protein for cell culture experiments, follow these technical steps:

  • Centrifuge the vial briefly before opening to ensure all lyophilized powder is at the bottom.

  • Reconstitute the protein in a suitable sterile buffer. Common options include:

    • Sterile water at a concentration of 0.1–1.0 mg/mL.
    • Sterile PBS (pH 7.2–7.4), optionally supplemented with 0.1% carrier protein such as endotoxinfree recombinant human serum albumin (HSA) or bovine serum albumin (BSA).
    • 20 mM TrisHCl, pH 8.0 is also recommended for carrierfree formulations.
  • Mix gently by swirling or tapping the vial. Do not vortex as this may denature the protein.

  • Allow the protein to dissolve completely (typically 5–10 minutes at room temperature).

Aliquoting and Storage:

  • If not used immediately, aliquot the reconstituted solution to avoid repeated freezethaw cycles.
  • For longterm storage, add a carrier protein (e.g., 0.1% HSA or BSA) to stabilize the protein.
  • Store aliquots at –20°C to –80°C.

Preparation for Cell Culture:

  • Before use, dilute the stock solution to the desired working concentration in cell culture medium. Typical working concentrations for bioassays range from 0.5–1.5 ng/mL for cell proliferation assays, but optimal concentrations should be empirically determined for your specific application.
  • Ensure all solutions are sterile and endotoxinfree to prevent adverse effects on cell cultures.

Summary Table: Reconstitution Options

BufferCarrier ProteinStock ConcentrationMixing MethodStorage Temperature
Sterile waterOptional (0.1% BSA/HSA)0.1–1.0 mg/mLGentle swirl/tap–20°C to –80°C
Sterile PBS (pH 7.2–7.4)Optional (0.1% BSA/HSA)0.2–0.5 mg/mLGentle swirl/tap–20°C to –80°C
20 mM TrisHCl, pH 8.0Optional (0.1% BSA/HSA)0.1–1.0 mg/mLGentle swirl/tap–20°C to –80°C

Best Practices:

  • Always consult the specific product datasheet or Certificate of Analysis for buffer recommendations and concentration ranges.
  • Use endotoxinfree reagents and sterile technique throughout preparation.
  • Avoid repeated freezethaw cycles by aliquoting stock solutions.

These protocols ensure optimal protein stability and bioactivity for cell culture applications.

References & Citations

1. Stanley, ER. et al. (1978) Nature 274: 168
2. Byrne, PV. et al. (1981) J. Cell. Biol. 91: 848
3. Bourette, RP. et al. (2000) Growth Factors 17: 155
4. Stanley, ER. et al. (1996) Bone 18: 355
5. Novak, U. et al. (1996) Oncogene 13: 2607
6. Teitelbaum, SL. et al. (2005) J Clin Invest. 115(12):341827.

Certificate of Analysis

IMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.
Page load link
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok